Preliminary studies of schizotypal subjects suggest that this disorder is phenomenologically, genetically, and biologically related to chronic schizophrenia as part of a continuum of schizophrenia-related disorders. However, this relationship remains to be definitively established in clinically identified schizotypal patients, relatively accessible population whose study is less likely to be confounded by chronic neuroleptic use or institutionalization than that of schizophrenic patients. The characterization of the psychobiologic relationship between schizophrenic and clinically identified schizotypal personality disorder patients thus represents an important step in the definition of the nosologic, genetic, and pathophysiologic boundaries of the schizophrenia-related continuum. Towards this end, the objectives of the studies proposed in this application are to evaluate three psychobiologic measures demonstrated to be abnormal in schizophrenic patients and preliminary studies of schizotypal individuals: smooth pursuit eye movement (SPEM) accuracy, the continuous performance task (CPT) and the backward masking test in schizotypal patients; in chronic schizophrenic patients; in comparably symptomatic controls, patients with other non-schizophrenia-related personality disorders; and in normal controls. The Holzman Thought Disorder Inventory (TDI), the Chapman psychosis-proneness scales and the Schedule for Interviewing DSM-III personality Disorders (SlDP) will be administered to characterize the schizophrenia-like psychologic disturbances in the schizotypal and other personality disordered patients, while less specific global and depressive symptomatology will be evaluated by the BPRS and Beck Depression Inventory respectively. Repeat testing of all of these variables at six month intervals for the first year following initial evaluation will enable a determination of the stability of these variables. Comparison of the psychobiologic measures between the groups will test the hypothesis that both schizophrenic and schizotypal patients differ from the two control groups on these measures. Multivariant analyses of the psychobiologic and psychologic variables by factors of time and diagnosis will be employed to help a determine to what extent any diagnostic group differences in the biologic variables are related to less specific state-related symptomatology and to what extent they are related to the """"""""core"""""""" schizotypal symptoms of social withdrawal, anhedonia, and subtle thought disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37MH042827-07
Application #
2245562
Study Section
Special Emphasis Panel (NSS)
Project Start
1989-02-01
Project End
1997-01-31
Budget Start
1995-03-01
Budget End
1996-01-31
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Psychiatry
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Mitropoulou, Vivian; Friedman, Lee; Zegarelli, Gayle et al. (2011) Eye tracking performance and the boundaries of the schizophrenia spectrum. Psychiatry Res 186:18-22
Haznedar, M Mehmet; Buchsbaum, Monte S; Hazlett, Erin A et al. (2004) Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res 71:249-62
Mitelman, Serge A; Shihabuddin, Lina; Brickman, Adam M et al. (2003) MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. Am J Psychiatry 160:2154-68
Koenigsberg, Harold W; Harvey, Philip D; Mitropoulou, Vivian et al. (2002) Characterizing affective instability in borderline personality disorder. Am J Psychiatry 159:784-8
Downhill Jr, J E; Buchsbaum, M S; Hazlett, E A et al. (2001) Temporal lobe volume determined by magnetic resonance imaging in schizotypal personality disorder and schizophrenia. Schizophr Res 48:187-99
Shihabuddin, L; Buchsbaum, M S; Hazlett, E A et al. (2001) Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry 58:877-84
Koenigsberg, H W; Harvey, P D; Mitropoulou, V et al. (2001) Are the interpersonal and identity disturbances in the borderline personality disorder criteria linked to the traits of affective instability and impulsivity? J Pers Disord 15:358-70
Roitman, S E; Mitropoulou, V; Keefe, R S et al. (2000) Visuospatial working memory in schizotypal personality disorder patients. Schizophr Res 41:447-55
Bergman, A J; Silverman, J M; Harvey, P D et al. (2000) Schizotypal symptoms in the relatives of schizophrenia patients: an empirical analysis of the factor structure. Schizophr Bull 26:577-86
Silverman, J M; Smith, C J; Guo, S L et al. (1998) Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disorders. Biol Psychiatry 43:97-106

Showing the most recent 10 out of 21 publications